论文部分内容阅读
本文选取了福布斯中国最佳上市家族企业50强中8家医药类家族企业近5年的财务数据为样本。一方面,通过分析家族企业自身优势和特点来阐述家族企业的自身发展潜力;另一方面,从比率分析和业绩指标等财务视角分析我国医药类上市家族企业的成长能力。从财务角度剖析医药类上市家族企业成功的内在驱动力,并为企业内外投资者提供借鉴。
This paper selects the financial data of eight pharmaceutical family-owned enterprises in the Forbes China Top 50 Listed Family Enterprises for nearly five years as a sample. On the one hand, it analyzes the self-development potential of family-owned enterprises by analyzing their own advantages and characteristics; on the other hand, analyzes the growth ability of the listed family-owned medical companies in China from the perspective of ratio analysis and performance indicators. From the financial point of view of pharmaceutical listed family business success of the inherent driving force, and to provide reference for both domestic and foreign investors.